Cover Image: Isabelle Aish, February 2026 By: Iarina Murasan, Contributing Writer (original version published in The Dose, a UAEM newsletter) … More
Category: a – Biology & Genetics
The Pharma Heroine: Frances Kelsey and the Thalidomide Tragedy
Cover Image: Lilly Guilbeault, January 2026 By: Sagit Yessim, Contributing Writer If you have ever taken CHEM 211, then chances … More
MMR vaccine hesitancy – mindset and misinformation
Cover Image: Ella Yang, February 2026 By: Isla Stiff, Contributing Writer Resurgence of Measles within Canada Measles is a highly contagious … More
Red Light, Blue Light: Illuminating a few health claims – Part 1
By: Jacob Van Oorschot, Contributing Writer Cover Image: Reno Zhu, Illustrator (original work) Among the greatest challenges I faced in … More
Empire in the bloodstream: The Opium Wars and their after-effects
Cover Image: Painting by Nikita de Jonge, January 2026 Article by: Parmida Talebi, Contributing Writer In the early nineteenth century, British … More
Parasitoidism acquaints a wasp with strange bedfellows
Virus particles used as gene delivery vectors by parasitoid wasps—and people? Cover image: Signe Dixon, February 2026 By: Jacob Van … More
The epigenetics of exercise: Strengthening your muscles and your mind
Cover Image: Liadan Lawson, February 2026 By: Becca Carballal, Contributing Writer Finals season is fast approaching, and with it are … More
Origins of the nervous system as told by sea sponges and comb jellies
Cover Image and Figures: Auden Akinc, February 2026 By: Jacob Van Oorschot, Contributing Writer Who branched off first: comb jellies … More
So, vampires would get bloodborne diseases, no?
Lately, I’ve been concerned for the health of vampires. While I may not bear the curse of eternal life, I clearly have a bit of extra time on my hands. But seriously, vampires’ strictly-blood diet has me worried, due to all the blood-borne diseases they would be exposed to.
Micro-allies in our gut help us fight cancer
Cancer immunotherapy has revolutionized oncology over the last three decades, but a serious problem remains: more than half of treated patients do not respond to the therapy. Recent research, including work at McGill, reveals that manipulating the microorganisms living in our gut could help improve treatment outcomes.
